01 Robotic and Patient-Specific Planning Are Reshaping Orthopedic Implant Procedures Orthopedic implant procedures are increasingly moving toward digitally planned and robot-assisted workflows that help surgeons improve implant positioning and alignment. Instead of relying only on conventional surgical measurements, newer systems combine imaging, intraoperative data, navigation, and robotic assistance to support more individualized joint replacement procedures. This shift is also encouraging implant manufacturers to connect their implant systems with digital planning platforms, creating integrated solutions rather than selling implants alone. The trend can improve workflow consistency while giving surgeons greater control over implant placement and alignment. It is particularly visible in knee and hip replacement, where precise positioning can influence functional outcomes and long-term implant performance. In July 2026, Stryker commercially launched Mako RPS in the U.S., combining handheld robotics, intraoperative planning, and its Triathlon Total Knee System for total knee replacement.
01 Rising Joint Replacement Demand Is Supporting Orthopedic Implant Use The growing need for hip, knee, and other joint replacement procedures is a major demand driver for orthopedic implants. Aging populations, osteoarthritis, reduced mobility, and longer life expectancy increase the number of patients requiring surgical treatment. Joint replacement is particularly important among older adults because restoring mobility can support independence and daily activities. Healthcare systems are also developing care pathways around these procedures, encouraging hospitals to improve surgical capacity and recovery services. As procedure volumes expand, demand increases for implants, fixation components, surgical instruments, and related technologies. The continued focus on restoring mobility rather than only managing symptoms provides a sustained clinical need for orthopedic implant procedures across major healthcare markets.
01 Value-Based Payment Models Can Increase Pressure on Implant Costs Orthopedic implant manufacturers face pricing pressure as hospitals and healthcare systems increasingly evaluate procedures according to total episode costs rather than implant price alone. Under bundled or episode-based payment models, hospitals can become financially responsible for costs associated with surgery, hospitalization, follow-up care, rehabilitation, and complications. This encourages providers to compare implant prices, clinical outcomes, readmission risks, and recovery requirements when selecting products. Manufacturers may therefore need to demonstrate measurable value rather than relying only on technological differentiation. Higher-priced implants can face resistance when hospitals believe lower-cost alternatives can provide comparable clinical performance. This pricing environment can limit premium-product adoption and place greater pressure on manufacturers to control production costs while maintaining quality and regulatory compliance.
01 Bioabsorbable Implants Create Opportunities Beyond Permanent Metal Fixation Bioabsorbable orthopedic implants are creating opportunities for manufacturers to develop fixation products that gradually break down after supporting bone healing. These materials can potentially reduce the need for later implant-removal procedures in selected applications and may offer different options for fracture fixation and bone repair. Advances in polymer and composite materials are expanding interest in screws, anchors, and other temporary fixation devices. Regulatory progress is also helping companies bring new bioabsorbable products into commercial use. Manufacturers that can demonstrate predictable strength, controlled degradation, biocompatibility, and reliable clinical performance may capture demand in trauma and sports-medicine applications. The opportunity is especially relevant where temporary mechanical support is preferred over permanent hardware.
01 Preventing Implant-Related Infection Remains a Critical Clinical Challenge Orthopedic implant manufacturers and healthcare providers must manage the risk of infections involving implanted devices. Surgical-site infections can affect tissues around an implant and may require antibiotics, additional medical treatment, or revision surgery. Because orthopedic implants remain inside the body, infection prevention requires coordinated control across implant manufacturing, sterilization, operating-room practices, patient preparation, and postoperative monitoring. Manufacturers therefore face pressure to maintain stringent production and sterilization processes while developing materials and surface technologies that support safe implantation. Hospitals must also maintain consistent infection-control procedures across increasingly high procedure volumes. Failure to control infection can increase treatment costs, prolong recovery, and contribute to implant revision, making infection prevention an important technical and operational challenge for the orthopedic implants industry.
June 2026 Smith+Nephew launched the CORI Shoulder application on its latest-generation CORI Surgical System, expanding its robotic-assisted orthopedic implant portfolio for shoulder arthroplasty and strengthening its digital orthopedic surgery platform.
May 2026 Smith+Nephew completed the acquisition of Integrity Orthopaedics, expanding its orthopedic reconstruction portfolio with innovative extremity implant technologies and strengthening its orthopedic implants business.
June 2025 Stryker received U.S. FDA 510(k) clearance for the Incompass Total Ankle System, expanding its orthopedic implant portfolio with a next-generation total ankle replacement platform integrating the technologies of its Inbone and Infinity systems.
June 2025 Smith+Nephew launched the AETOS Shoulder System in additional markets, expanding its orthopedic implant portfolio for shoulder reconstruction and supporting growth in its trauma and extremities business.